L. Pauer

1.4k total citations
39 papers, 1.1k citations indexed

About

L. Pauer is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, L. Pauer has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 24 papers in Psychiatry and Mental health and 13 papers in Cognitive Neuroscience. Recurrent topics in L. Pauer's work include Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers), Musculoskeletal pain and rehabilitation (23 papers) and Pain Management and Placebo Effect (13 papers). L. Pauer is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers), Musculoskeletal pain and rehabilitation (23 papers) and Pain Management and Placebo Effect (13 papers). L. Pauer collaborates with scholars based in United States, United Kingdom and Canada. L. Pauer's co-authors include Joseph C. Arezzo, Julio Rosenstock, Linda LaMoreaux, Daniel J. Clauw, Ed Whalen, Richard E. Harris, Lesley M. Arnold, Tobias Schmidt‐Wilcke, Vitaly Napadow and Johnson P. Hampson and has published in prestigious journals such as The British Journal of Psychiatry, Anesthesiology and British Journal of Anaesthesia.

In The Last Decade

L. Pauer

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Pauer United States	19	407	405	402	252	206	39	1.1k
Andrew Clair United States	15	218 0.5×	314 0.8×	299 0.7×	153 0.6×	110 0.5×	35	698
Lloyd Knapp United States	20	592 1.5×	770 1.9×	285 0.7×	391 1.6×	582 2.8×	36	1.9k
Rafael Gálvez Spain	21	840 2.1×	224 0.6×	613 1.5×	224 0.9×	364 1.8×	67	1.6k
Fujun Wang United States	10	459 1.1×	288 0.7×	427 1.1×	165 0.7×	257 1.2×	17	888
A. J. Clark Canada	14	244 0.6×	125 0.3×	381 0.9×	160 0.6×	68 0.3×	24	833
Michael Tuchman United States	18	1.0k 2.6×	390 1.0×	357 0.9×	197 0.8×	537 2.6×	24	1.6k
Xavier Masramón Spain	15	189 0.5×	321 0.8×	166 0.4×	98 0.4×	66 0.3×	24	729
U. Sharma United States	6	754 1.9×	189 0.5×	284 0.7×	193 0.8×	427 2.1×	13	1.1k
Kristina B. Svendsen Denmark	14	286 0.7×	56 0.1×	307 0.8×	204 0.8×	405 2.0×	24	1.1k
Thomas Toelle Germany	12	434 1.1×	151 0.4×	373 0.9×	116 0.5×	210 1.0×	18	859

Countries citing papers authored by L. Pauer

Since Specialization

Citations

This map shows the geographic impact of L. Pauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Pauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Pauer more than expected).

Fields of papers citing papers by L. Pauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Pauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Pauer. The network helps show where L. Pauer may publish in the future.

Co-authorship network of co-authors of L. Pauer

This figure shows the co-authorship network connecting the top 25 collaborators of L. Pauer. A scholar is included among the top collaborators of L. Pauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Pauer. L. Pauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiao, Huji Xu, Zhiyi Zhang, et al.. (2021). Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects. Journal of Pain Research. Volume 14. 537–548. 5 indexed citations

Arnold, Lesley M., Kenneth N. Schikler, Lucinda Bateman, et al.. (2016). Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatric Rheumatology. 14(1). 46–46. 37 indexed citations

Argoff, Charles E., et al.. (2016). Pregabalin Improves Pain Scores in Patients with Fibromyalgia Irrespective of Comorbid Osteoarthritis. Pain Medicine. 17(11). 2100–2108. 7 indexed citations

Kairys, Anson, L. Pauer, Tobias Schmidt‐Wilcke, et al.. (2016). Association of Alterations in Gray Matter Volume With Reduced Evoked‐Pain Connectivity Following Short‐Term Administration of Pregabalin in Patients With Fibromyalgia. Arthritis & Rheumatology. 68(6). 1511–1521. 18 indexed citations

Raskin, Philip, Cynthia Huffman, Lorraine Yurkewicz, et al.. (2015). Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions. Clinical Journal of Pain. 32(3). 203–210. 20 indexed citations

Huffman, Cynthia, Brett R. Stacey, Michael Tuchman, et al.. (2015). Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking. Clinical Journal of Pain. 31(11). 946–958. 24 indexed citations

Arnold, Lesley M., Piercarlo Sarzi‐Puttini, Pierre Arsenault, et al.. (2015). Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study. The Journal of Rheumatology. 42(7). 1237–1244. 35 indexed citations

Arnold, Lesley M., Pierre Arsenault, Cynthia Huffman, et al.. (2014). Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study. Current Medical Research and Opinion. 30(10). 2069–2083. 23 indexed citations

Arnold, Lesley M., Birol Emir, L. Pauer, Malca Resnick, & Andrew Clair. (2014). Time to Improvement of Pain and Sleep Quality in Clinical Trials of Pregabalin for the Treatment of Fibromyalgia. Pain Medicine. 16(1). 176–185. 20 indexed citations

10.

Harris, Richard E., Vitaly Napadow, John P. Huggins, et al.. (2013). Pregabalin Rectifies Aberrant Brain Chemistry, Connectivity, and Functional Response in Chronic Pain Patients. Anesthesiology. 119(6). 1453–1464. 197 indexed citations

11.

Raskin, Philip, Cynthia Huffman, Cory Toth, et al.. (2013). Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy. Clinical Journal of Pain. 30(5). 379–390. 30 indexed citations

12.

Pauer, L., Gary Atkinson, T.K. Murphy, Danielle Petersel, & Bernhardt Zeiher. (2012). Long-term Maintenance of Response Across Multiple Fibromyalgia Symptom Domains in a Randomized Withdrawal Study of Pregabalin. Clinical Journal of Pain. 28(7). 609–614. 11 indexed citations

13.

Arnold, Lesley M., Birol Emir, T.K. Murphy, et al.. (2012). Safety Profile and Tolerability of Up to 1 Year of Pregabalin Treatment in 3 Open-Label Extension Studies in Patients With Fibromyalgia. Clinical Therapeutics. 34(5). 1092–1102. 21 indexed citations

14.

Getz, Kenneth, Zachary Hallinan, Marla Jo Brickman, et al.. (2012). Meeting the obligation to communicate clinical trial results to study volunteers. Expert Review of Clinical Pharmacology. 5(2). 149–156. 13 indexed citations

15.

Pauer, L., Andreas Winkelmann, Pierre Arsenault, et al.. (2011). An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia. The Journal of Rheumatology. 38(12). 2643–2652. 70 indexed citations

16.

Murphy, Kevin, et al.. (2009). Long-term safety and tolerability of pregabalin treatment in three open-label extension studies in patients with fibromyalgia. Journal of Pain. 10(4). S58–S58. 3 indexed citations

17.

Arezzo, Joseph C., Julio Rosenstock, Linda LaMoreaux, & L. Pauer. (2008). Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial. BMC Neurology. 8(1). 33–33. 153 indexed citations

18.

Montgomery, Stuart, Krai Chatamra, L. Pauer, Ed Whalen, & F. Baldinetti. (2008). Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. The British Journal of Psychiatry. 193(5). 389–394. 90 indexed citations

19.

Carrasco, Melisa, et al.. (2007). Preliminary results evaluating cognitive function in elderly from double-blind, placebo-controlled trial of pregabalin in generalized anxiety disorder (gad). European Psychiatry. 22. S279–S280. 2 indexed citations

20.

Pauer, L., Casey Cunningham, A. S. Williams, et al.. (2004). Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors. Cancer Investigation. 22(6). 886–896. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact